Immunomodulation and immunopharmacology in heart failure

G Markousis-Mavrogenis, L Baumhove… - Nature Reviews …, 2024 - nature.com
The immune system is intimately involved in the pathophysiology of heart failure. However, it
is currently underused as a therapeutic target in the clinical setting. Moreover, the …

Associations between systemic immunity-inflammation index and heart failure: Evidence from the NHANES 1999–2018

H Zheng, Z Yin, X Luo, Y Zhou, F Zhang… - International Journal of …, 2024 - Elsevier
Background Heart failure (HF) is a disease closely associated with inflammation, and the
systemic immune-inflammation index (SII) is a novel inflammatory marker. Therefore, this …

Pathophysiologic processes and novel biomarkers associated with congestion in heart failure

P Pandhi, JM Ter Maaten, SD Anker, LL Ng, M Metra… - Heart Failure, 2022 - jacc.org
Background Congestion is the main driver behind symptoms of heart failure (HF), but
pathophysiology related to congestion remains poorly understood. Objectives Using …

Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study

RIS Alnuwaysir, N Grote Beverborg… - European journal of …, 2022 - Wiley Online Library
Aims Whereas the combination of anaemia and chronic kidney disease (CKD) has been
extensively studied in patients with heart failure (HF), the contribution of iron deficiency (ID) …

[HTML][HTML] Biomarkers of myocardial injury and remodeling in heart failure

B Ponikowska, G Iwanek, A Zdanowicz… - Journal of Personalized …, 2022 - mdpi.com
With its complicated pathophysiology, high incidence and prevalence, heart failure remains
a major public concern. In hopes of improving diagnosis, treatment and prognosis, the utility …

[HTML][HTML] Multi-omics analyses identify molecular signatures with prognostic values in different heart failure aetiologies

JP Aboumsallem, C Shi, S De Wit… - Journal of molecular and …, 2023 - Elsevier
Background Heart failure (HF) is the leading cause of morbidity and mortality worldwide, and
there is an urgent need for more global studies and data mining approaches to uncover its …

[HTML][HTML] Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints

M Jarlborg, C Gabay - Cytokine, 2022 - Elsevier
Abstract Interleukin (IL)-6 is produced locally in response to an inflammatory stimulus, and is
able to induce systemic manifestations at distance from the site of inflammation. Its unique …

[HTML][HTML] Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy

Y Li, W Zhang, Y Dai, K Chen - Frontiers in Genetics, 2022 - frontiersin.org
Background: Hypertrophic cardiomyopathy (HCM) is the main cause of sudden cardiac
death among young adults, yet its pathogenesis remains vague. N6-methyladenosine (m6A) …

Multiomics analysis provides novel pathways related to progression of heart failure

W Ouwerkerk, JP Belo Pereira, T Maasland… - Journal of the American …, 2023 - jacc.org
Background Despite major advances in pharmacological treatment for patients with heart
failure, residual mortality remains high. This suggests that important pathways are not yet …

Quantifying inflammation using interleukin‐6 for improved phenotyping and risk stratification in acute heart failure

E Michou, D Wussler, M Belkin… - European Journal of …, 2023 - Wiley Online Library
Aims Systemic inflammation may be central in the pathophysiology of acute heart failure
(AHF). We aimed to assess the possible role of systemic inflammation in the …